Pharmafile Logo

Kraeber (UK) Ltd

The family owned business, Kraeber & Co GmbH, is an independent, technology based enterprise which was founded on the 1st January 1980 in Hamburg. Hanseatic tradition together with courageous entrepreneurship characterize our company. We are committed to open and global competition which we stand up with our service capabilities. Our emphasis is the development, production, marketing and sales of active pharmaceutical ingredients (APIs) of the highest purity. Kraeber has evolved into a niche marketer and supplier. By continously innovating productions, we became the quality market leader in Europe and in other parts of the world for many of our products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

16 The Street, Saxon Street, Newmarket, Suffolk, CB8 9RU, United Kingdom
+44 (0)1638 731 297

 Latest Content from PMHub 

Webcast

Monitoring the impact of COVID-19 on the market access landscape

Covid-19 redefines rules of customer engagement

Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs

Ongoing Virtual Communication between MSLs and Physicians: a Customer Story

Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians.

The concordance conundrum: understanding the complexities of behaviour change

Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved.

The concordance conundrum: creating space for open dialogue

Growing numbers of patients want a partnership model with their HCP, whereby both parties are equally involved in the decision-making process. This model has been linked with an increase in...

Responding to dynamic shifts in value communications

OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies.

The concordance conundrum: the tech divide

COVID-19 resulted in the rapid adoption of virtual consultations; while they offer increased accessibility and convenience for some, are they really all they are cracked up to be? Consultations in...

Using Artificial Intelligence to Transform Pharma

Videos and Podcasts | September 24, 2020 | Impetus Digital

Dr. Andree Bates, Founder & CEO of Eularis, discusses how Eularis helps healthcare teams utilize AI and “Future Tech” to solve their biggest commercial challenges and deliver measurable growth. Among many...

Transforming Unstructured Healthcare Information into Real-World Evidence & Life Saving Insights

Videos and Podcasts | September 24, 2020 | Impetus Digital

Aaron Leibtag, CEO & Co-Founder of Pentavere Research Group, discusses his transition from being an Organizational Transformation Leader to co-founding a startup focused on healthcare technology. We also dive into how...